An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease
暂无分享,去创建一个
Atul Narkhede | Giuseppe Tosto | Howard Andrews | Richard Mayeux | Adam M Brickman | A. Brickman | Atul Narkhede | R. Mayeux | J. Manly | N. Schupf | H. Andrews | J. Vonsattel | G. Tosto | Batool Rizvi | Yian Gu | Jennifer J Manly | Nicole Schupf | Jean Paul Vonsattel | Yian Gu | Vanessa A. Guzman | Jose Gutierrez | Batool Rizvi | Vanessa Guzman | J. Gutierrez | B. Rizvi
[1] B. Winblad,et al. Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden , 2013, Neurology.
[2] Paul K Crane,et al. lordif: An R Package for Detecting Differential Item Functioning Using Iterative Hybrid Ordinal Logistic Regression/Item Response Theory and Monte Carlo Simulations. , 2011, Journal of statistical software.
[3] Nick C Fox,et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.
[4] S. Tarantini,et al. Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. , 2017, American journal of physiology. Heart and circulatory physiology.
[5] Anders Wallin,et al. Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. , 2005, Clinical chemistry.
[6] K. Marder,et al. The APOE- (cid:101) 4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics , 2001 .
[7] R. Petersen,et al. Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States , 2011, Alzheimer's & Dementia.
[8] V. Hachinski. Stroke and Alzheimer disease: fellow travelers or partners in crime? , 2011, Archives of neurology.
[9] Sterling C. Johnson,et al. Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function , 2014, Neurobiology of Aging.
[10] W. Jagust,et al. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core , 2010, Alzheimer's & Dementia.
[11] A. Brickman. Contemplating Alzheimer’s Disease and the Contribution of White Matter Hyperintensities , 2013, Current Neurology and Neuroscience Reports.
[12] Evan Fletcher,et al. Fully-Automated White Matter Hyperintensity Detection with Anatomical Prior Knowledge and without FLAIR , 2009, IPMI.
[13] Benjamin F. J. Verhaaren,et al. Is dementia incidence declining? , 2012, Neurology.
[14] HERMAN BUSCHKE,et al. Evaluating storage, retention, and retrieval in disordered memory and learning , 1974, Neurology.
[15] A. Brickman,et al. Structural MRI Predictors of Late-Life Cognition Differ Across African Americans, Hispanics, and Whites. , 2015, Current Alzheimer research.
[16] Nick C Fox,et al. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network , 2016, Annals of neurology.
[17] Nick C Fox,et al. Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic , 2018, Alzheimer's Research & Therapy.
[18] Alan J. Thomas,et al. Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease , 2017, Acta Neuropathologica.
[19] L. Thal,et al. Clinical Dementia Rating training and reliability in multicenter studies , 1997, Neurology.
[20] R. Nandhagopal,et al. Thalamic disequilibrium syndrome after thrombolytic therapy for acute myocardial infarction , 2005, Neurology.
[21] J. Trojanowski,et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. , 2013, Brain : a journal of neurology.
[22] P. Koudstaal,et al. Silent brain infarcts: a systematic review , 2007, The Lancet Neurology.
[23] Sudha Seshadri,et al. Association of MRI Markers of Vascular Brain Injury With Incident Stroke, Mild Cognitive Impairment, Dementia, and Mortality: The Framingham Offspring Study , 2010, Stroke.
[24] T. Beach,et al. Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center , 2005, Neurology.
[25] Trevor Hastie,et al. Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent. , 2011, Journal of statistical software.
[26] C. Gong,et al. From Chronic Cerebral Hypoperfusion to Alzheimer-Like Brain Pathology and Neurodegeneration , 2014, Cellular and Molecular Neurobiology.
[27] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[28] C. DeCarli,et al. Impact of multiple pathologies on the threshold for clinically overt dementia , 2017, Acta Neuropathologica.
[29] V. Hachinski,et al. Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer's disease. , 1991, Archives of neurology.
[30] D. Bennett,et al. Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery , 2017, PLoS medicine.
[31] D. Rueckert,et al. Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease , 2011, PloS one.
[32] B. Zlokovic. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.
[33] Yaakov Stern,et al. Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers? , 2010, Neuropsychology.
[34] O. Wiestler,et al. Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline , 2003, Journal of neuropathology and experimental neurology.
[35] Bin Wang,et al. Deconvolution Estimation in Measurement Error Models: The R Package decon. , 2011, Journal of statistical software.
[36] A. Rahmim,et al. Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition , 2017, JAMA.
[37] Yaakov Stern,et al. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. , 2008, Archives of neurology.
[38] Yaakov Stern,et al. The APOE-∊4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics , 1998 .
[39] R. Sacco,et al. Brain Perivascular Spaces as Biomarkers of Vascular Risk: Results from the Northern Manhattan Study , 2017, American Journal of Neuroradiology.
[40] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[41] Yaakov Stern,et al. Frequency and course of mild cognitive impairment in a multiethnic community , 2008, Annals of neurology.
[42] D. Teichberg,et al. Local histogram correction of MRI spatially dependent image pixel intensity nonuniformity , 1996, Journal of magnetic resonance imaging : JMRI.
[43] C. DeCarli,et al. Subclinical cerebrovascular disease in mild cognitive impairment , 2009, Neurology.
[44] Jeffrey A. James,et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. , 2008, Archives of neurology.
[45] B. Dickerson,et al. MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults , 2012, Neurology.
[46] M. Schumacher,et al. Incidence of Dementia over Three Decades in the Framingham Heart Study. , 2016, The New England journal of medicine.
[47] J. Bond,et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II , 2013, The Lancet.
[48] C. Dufouil,et al. Incidence of Dementia over Three Decades in the Framingham Heart Study. , 2016, The New England journal of medicine.
[49] Alejandro F Frangi,et al. Vascular dysfunction in the pathogenesis of Alzheimer's disease — A review of endothelium-mediated mechanisms and ensuing vicious circles , 2015, Neurobiology of Disease.
[50] A. Brickman,et al. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence , 2015, Neurobiology of Aging.
[51] Lawrence S. Honig,et al. Atherosclerosis and AD : Analysis of data from the US national Alzheimer's coordinating center. Author's reply , 2005 .
[52] K. Jellinger,et al. The overlap between vascular disease and Alzheimer’s disease - lessons from pathology , 2014, BMC Medicine.